Press "Enter" to skip to content

Bevacizumab in combination with either FOLFOX-4 or XELOX-2 in first-line treatment of patients with metastatic colorectal cancer: A multicenter randomized phase II trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802) – MD Linx

admin 0

Bevacizumab in combination with either FOLFOX-4 or XELOX-2 in first-line treatment of patients with metastatic colorectal cancer: A multicenter randomized phase II trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)  MD Linx
“colorectal cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *